In recent history, we've made some incredible medical innovations through trials. But not everyone has access. Let's change that.
Throughout the world, if you fall within a minority or otherwise marginalized group, it's not only more likely that you won't have access to clinical trial research but also that a breakthrough drug hasn't been adequately tested on people of your ethnicity or background. Sponsors want their trials to be inclusive because it leads to more robust analysis, faster drug approvals, and improved patient outcomes. However, it's not always easy to engage underserved patients in research.
That's where community sites come in. By partnering with investigators who already have trusted relationships with patients and deep ties to the community, sponsors can reach untapped patient populations.
Inato's Inclusive Research Program connects sponsors with proven-diverse sites, making sure the latest medical innovations are safe and effective for everyone.